Infarction Cerebral Completed Phase 2 Trials for Fluoxetine (DB00472)

Also known as: Cerebral Infarct / Cerebral Infarction / Cerebral Infarctions / Cerebral infarction, unspecified / Cerebral infarction (disorder) / Infarct cerebral / Occlusion of cerebral arteries / Occlusion of cerebral artery (disorder) / Cerebral artery occlusion, unspecified / Cerebral artery occlusion

DBCOND0158720 (Infarction Cerebral)Completed2 IdentifierTitlePurposeDrugs
NCT03448159Fluoxetine Opens Window to Improve Motor Recovery After StrokeTreatment